Cost of illness of breast cancer in Japan: trends and future projections.
Cost of illness of breast cancer in Japan: trends and future projections.
复制标题
DOI：
10.1186/s13104-015-1516-y
复制
发表时间：
2015-10-05
影响因子：
1.8
通讯作者：
Hasegawa T
中科院分区：
文献类型：
--
作者：
Matsumoto K;Haga K;Kitazawa T;Seto K;Fujita S;Hasegawa T
乳腺癌是日本妇女死亡的主要原因。本研究的目的是估计和预测日本乳腺癌的经济负担，并确定推动乳腺癌经济负担变化的关键因素。我们使用政府统计数据计算了1996年至2020年每3年的疾病成本（COI）。COI通过直接成本、发病率成本和死亡率成本的总和计算。从1996年到2011年，COI呈上升趋势。2011年的COI（6，970亿日元）是1996年（4，070亿日元）的1.7倍。死亡成本约占总COI的65- 70%，是COI增加的主要因素。据预测，到2020年，COI将继续呈上升趋势（6994 - 7438亿日元，取决于模型），但增长率将下降。自1996年以来，乳腺癌的COI一直在稳步上升。虽然增长率预计将趋于平稳，但乳腺癌的平均死亡年龄仍低于其他癌症，在可预见的未来，乳腺癌的相对经济负担将继续增加。
Breast cancer is a major cause of death for women in Japan. The objectives of this study were to estimate and project the economic burden associated with breast cancer in Japan and identify the key factors that drive the change of the economic burden of breast cancer. We calculated the cost of illness (COI) every 3 years from 1996 to 2020 using governmental statistics. COI was calculated by summing the direct costs, morbidity costs, and mortality costs. From 1996 to 2011 COI was trending upward. COI in 2011 (697 billion yen) was 1.7-times greater than that in 1996 (407 billion yen). The mortality costs accounted for approximately 65–70 % of the total COI and were a major contributing factor to increase in COI. It was predicted that COI would continue to trend upwards until 2020 (699.4–743.8 billion yen depending on the model), but the rate of increase would decline. COI of breast cancer has been steadily increasing since 1996. While the rate of increase is expected to plateau, the average age at death from breast cancer is still less than that from other cancers, and the relative economic burden of breast cancer will continue to increase in the foreseeable future.